Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.52 |
| ▸ | MEN1 | O00255 | 1/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.52 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.48 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.48 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.48 |
| ▸ | GAA | P10253 | 2/20 | 0.46 |
| ▸ | CA1 | P00915 | 2/20 | 0.44 |
| ▸ | CA2 | P00918 | 2/20 | 0.44 |
| ▸ | MMP1 | P03956 | 2/20 | 0.44 |
| ▸ | MMP9 | P14780 | 2/20 | 0.44 |
| ▸ | MMP13 | P45452 | 2/20 | 0.44 |
| ▸ | MMP2 | P08253 | 1/20 | 0.44 |
| ▸ | MMP8 | P22894 | 1/20 | 0.44 |
| ▸ | CA12 | O43570 | 1/20 | 0.43 |
| ▸ | CA3 | P07451 | 1/20 | 0.43 |
| ▸ | CA6 | P23280 | 1/20 | 0.43 |
| ▸ | CA5A | P35218 | 1/20 | 0.43 |
| ▸ | CA7 | P43166 | 1/20 | 0.43 |
| ▸ | CA9 | Q16790 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5853798 | 0.82 | ALDH1A1 (0.50) | ALDH1A1MEN1KMT2ACYP3A4CYP2C9 | |
| SCHEMBL12143762 | 0.80 | ALDH1A1 (0.53) | ALDH1A1MEN1KMT2ACYP3A4CYP2C9 | |
| SCHEMBL9811491 | 0.79 | ALDH1A1 (0.47) | ALDH1A1MEN1KMT2ACYP3A4CYP2C9 | |
| SCHEMBL31420199 | 0.78 | ALDH1A1 (0.47) | ALDH1A1MEN1KMT2ACYP3A4CYP2C9 | |
| SCHEMBL28376606 | 0.78 | ALDH1A1 (0.47) | ALDH1A1MEN1KMT2ACYP3A4CYP2C9 | |
| SCHEMBL20958158 | 0.76 | ALDH1A1 (0.42) | ALDH1A1MEN1KMT2ACYP3A4CYP2C9 | |
| SCHEMBL10589227 | 0.76 | ALDH1A1 (0.42) | ALDH1A1MEN1KMT2ACYP3A4CYP2C9 | |
| SCHEMBL12144534 | 0.74 | ALDH1A1 (0.46) | ALDH1A1MEN1KMT2ACYP3A4CYP2C9 | |
| SCHEMBL30565133 | 0.73 | GAA (0.59) | ALDH1A1MEN1KMT2ACYP3A4CYP2C9 | |
| SCHEMBL31004986 | 0.73 | ALDH1A1 (0.49) | ALDH1A1MEN1KMT2ACYP3A4CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12297157-B2 | 18F-labeled peptide ligands useful in PET and Cerenkov luminescene imaging | CORNELL UNIVERSITY (US) | 2025-05-13 | — | — | US | disclosed |
| EP-4249005-A2 | 18F-LABELED TRIAZOLE CONTAINING PSMA INHIBITORS | Cornell University (US) | 2023-09-27 | — | — | EP | disclosed |
| EP-3493856-B1 | 18F-LABELED TRIAZOLE CONTAINING PSMA INHIBITORS | UNIV CORNELL (US) | 2023-08-09 | — | — | EP | disclosed |
| US-20220194904-A1 | 18F-LABELED TRIAZOLE CONTAINING PSMA INHIBITORS | CORNELL UNIVERSITY (US) | 2022-06-23 | — | — | US | disclosed |
| US-20200317588-A1 | 18F-LABELED PEPTIDE LIGANDS USEFUL IN PET AND CERENKOV LUMINESCENE IMAGING | CORNELL UNIVERSITY (US) | 2020-10-08 | — | — | US | disclosed |
| EP-3176155-B1 | 1,2-BIS-(4,7-DIMETHYL-1,4,7-TRIAZACYCLONON-1-YL)-ETHANE AND INTERMEDIATE FOR THE SYNTHESIS OF SAME | CATEXEL LTD (GB) | 2019-09-25 | — | — | EP | disclosed |
| EP-3493856-A1 | 18F-LABELED TRIAZOLE CONTAINING PSMA INHIBITORS | Cornell University (US) | 2019-06-12 | — | — | EP | disclosed |
| WO-2018005625-A1 | 18F-LABELED TRIAZOLE CONTAINING PSMA INHIBITORS | CORNELL UNIVERSITY (US) | 2018-01-04 | — | — | WO | disclosed |
| US-20170369454-A1 | 18F-LABELED TRIAZOLE CONTAINING PSMA INHIBITORS | UNIV CORNELL (US) | 2017-12-28 | — | — | US | disclosed |
| EP-3176155-A1 | 1,2-BIS-(4,7-DIMETHYL-1,4,7-TRIAZACYCLONON-1-YL)-ETHANE AND INTERMEDIATE FOR THE SYNTHESIS OF SAME | Catexel Limited (GB) | 2017-06-07 | — | — | EP | disclosed |
| WO-2012003598-A1 | INTERMEDIATES FOR THE SYNTHESIS OF 1,2-BIS(4,7-DIMETHYL-1,4,7-TRIAZACYCLONON-1-YL)-ETHANE AND PREPARATION METHOD THEREOF | UNILEVER PLC (GB) | 2012-01-12 | — | — | WO | disclosed |
| WO-2012003599-A1 | METHODS FOR THE SYNTHESIS OF BIS (TRIAZACYCLONONANE) LIGANDS | UNILEVER PLC (GB) | 2012-01-12 | — | — | WO | disclosed |
| EP-1729818-B8 | CONTRAST AGENTS FOR MAGNETIC RESONANCE IMAGING | CENTRE NAT RECH SCIENT (FR) | 2010-02-17 | — | — | EP | disclosed |
| EP-1729818-B1 | CONTRAST AGENTS FOR MAGNETIC RESONANCE IMAGING | CENTRE NAT RECH SCIENT (FR) | 2009-09-23 | — | — | EP | disclosed |
| US-20070218010-A1 | Contrast Agents for Magnetic Resonance Imaging | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2007-09-20 | — | — | US | disclosed |
| EP-1729818-A2 | CONTRAST AGENTS FOR MAGNETIC RESONANCE IMAGING | Centre National de la Recherche Scientifique (CNRS) (FR) | 2006-12-13 | — | — | EP | disclosed |
| WO-2005094903-A2 | CONTRAST AGENTS FOR MAGNETIC RESONANCE IMAGING | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2005-10-13 | — | — | WO | disclosed |
| US-4639365-A | Gadolinium chelates as NMR contrast agents | THE BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 1987-01-27 | — | — | US | disclosed |
| EP-0198051-A1 | GADOLINIUM CHELATES AS NMR CONTRAST AGENTS | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 1986-10-22 | — | — | EP | disclosed |
| WO-1986002352-A1 | GADOLINIUM CHELATES AS NMR CONTRAST AGENTS | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 1986-04-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200317588-A1 | 18F-LABELED PEPTIDE LIGANDS USEFUL IN PET AND CERENKOV LUMINESCENE IMAGING | VIP, CALCA, GLP1R | ALDH1A1 4664/4885MEN1 67/4885KMT2A 4516/4885 |
| US-20070218010-A1 | Contrast Agents for Magnetic Resonance Imaging | MAG, SLC40A1, FABP7 | ALDH1A1 2554/4885MEN1 12/4885KMT2A 1289/4885 |
| US-12297157-B2 | 18F-labeled peptide ligands useful in PET and Cerenkov luminescene imaging | VIP, CALCA, GLP1R | ALDH1A1 4664/4885MEN1 67/4885KMT2A 4516/4885 |
| US-20170369454-A1 | 18F-LABELED TRIAZOLE CONTAINING PSMA INHIBITORS | PSMA3, FOLH1, PSMA1 | ALDH1A1 1262/4885MEN1 107/4885KMT2A 1419/4885 |
| US-20220194904-A1 | 18F-LABELED TRIAZOLE CONTAINING PSMA INHIBITORS | PSMA3, FOLH1, PSMA1 | ALDH1A1 1262/4885MEN1 107/4885KMT2A 1419/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.